Almirall SA is a low-risk pharmaceutical company based in Spain. With an ESG score of 16.3, the company focuses on developing and selling pharmaceutical products across various therapeutic areas including dermatology, respiratory, and gastrointestinal. Operating in multiple segments, Almirall SA's key area of operation is medical dermatology in Europe, with a presence in other continents through subsidiaries.